New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
November 6, 2012
14:58 EDTNVONovo Nordisk volatility elevated into FDA Drugs Advisory Committee Meeting
Novo Nordisk November call option implied volatility is at 48, December is at 29, March is at 24; compared to its 26-week average of 26 according to Track Data, suggesting larger near term price movement into a FDA--CDER - Endocrinologic and Metabolic Drugs Advisory Committee Meeting on November 8.
News For NVO From The Last 14 Days
Check below for free stories on NVO the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
September 1, 2014
13:23 EDTNVONovo Nordisk launches diabetes drug Ryzodeg in Mexico, Reuters says
Subscribe for More Information
August 31, 2014
14:04 EDTNVOWorldwide Business Research to hold a conference
Subscribe for More Information
August 26, 2014
10:18 EDTNVONovo Nordisk has no plans for large acquisitions, WSJ says
Lars Sorensen, the CEO of Denmark-based Novo Nordisk, says that despite the increased deal-making activity in the global pharmaceutical industry of late, Novo Nordisk has no plans to acquire any entity that it can't fund through its own cash flows, says the Wall Street Journal. Reference Link

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use